Abstract
Topical administration of guanethidine leads to a "chemical postganglionic sympathectomy" that causes a hypersensitivity to epinephrine in the eye. Therefore, even low concentrations of epinephrine added to guanethidine lower intraocular pressure efficiently in cases of open-angle glaucoma. In order to test the feasibility of a therapy with both low dosages and minimal effective concentrations, at the same time avoiding the disadvantages of topical parasympathicomimetic treatment in normalizing intraocular pressure, a long-term study of ten patients presenting with confirmed open-angle glaucoma is being carried out. It has now been running for 15 months. A collyrium containing 1.0% guanethidine and 0.2% epinephrine is administered topically. The results and the statistical evaluation confirm a significant lowering of intraocular pressure without triggering any signs of tachyphylaxy during the whole duration of the trial. This represents a further alternative to nonmiotic treatment of open-angle glaucoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.